EU looks to boost protective trade policy against Chinese imports

The EU is moving closer to strengthening EU stockpiles and production of key medicines under its Critical Medicines Act (CMA). The new rules, agreed by the European Parliament and ministers from member states in May, will incentivise EU-based manufacturing of critical medicines and their active ingredients. There are indications that EU lawmakers are planning similar rules for chemicals and other sectors, but these are not yet as far advanced.